Journeys Metabolic | WebDisclosure

Switch to English

10761	Sociétés
231316	Mots-clés
159732	Articles
122987	Communiqués

Accueil
Sociétés
Journeys Metabolic

BRÈVE

publiée le 07/03/2024 à 15:05, il y a 2 années 4 mois

CoxHealth and Journeys Metabolic Partner to Tackle Metabolic Disease

Health Technology Value-based Care Digital Health Metabolic Disease Lifestyle Modification
BRÈVE

publiée le 07/03/2024 à 15:05, il y a 2 années 4 mois

CoxHealth et Journeys Metabolic s'associent pour lutter contre les maladies métaboliques

Santé Numérique Soins Basés Sur La Valeur Technologie De La Santé Maladie Métabolique Modification Du Mode De Vie
COMMUNIQUÉ DE PRESSE

publié le 07/03/2024 à 15:00, il y a 2 années 4 mois

CoxHealth and Journeys Metabolic Partner to Tackle Metabolic Disease
Partnership between Journeys Metabolic and CoxHealth aims to reverse metabolic disease in Southwest Missouri through a digital health program. Program offers personalized content, food tracking, and biomarker device for individuals

Population Health Metabolic Disease Journeys Metabolic CoxHealth Digital Health Program

Les Echos

Publié le 22/07/2026 à 18:19, il y a 5 heures 16 minutes

Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 5 heures 16 minutes

Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 5 heures 50 minutes

Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 5 heures 50 minutes

Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 5 heures 55 minutes

Report on share repurchases from 15 to 21 July 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 22/07/2026 à 15:00, il y a 8 heures 35 minutes

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 8 heures 35 minutes

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:50, il y a 8 heures 45 minutes

Hillcrest Enters AI Datacenter Ecosystem
Publié le 22/07/2026 à 14:35, il y a 9 heures

Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 9 heures 5 minutes

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Voir tout ACCESSWIRE

EQS Group

Publié le 22/07/2026 à 22:20, il y a 1 heure 14 minutes

Quantinuum Appoints Chief Legal Officer and Chief People Officer
Publié le 22/07/2026 à 21:01, il y a 2 heures 33 minutes

EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Publié le 22/07/2026 à 20:45, il y a 2 heures 49 minutes

Increase in Equity to Accelerate Growth
Publié le 22/07/2026 à 20:44, il y a 2 heures 50 minutes

EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Publié le 22/07/2026 à 20:08, il y a 3 heures 26 minutes

EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026